Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-23

Clinical Trial Update: Effect on the Adherence to Glaucoma Eye Drops by Improving Patient Understanding and Using a Tele-reminder System [Phase 2]

View source ↗

Summary

Phase 2 trial assessing how improved patient understanding and a tele-reminder system affect adherence to glaucoma eye drops.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National University Health System, Singapore | Conditions: Glaucoma | Phase 2 | Status: COMPLETED